Skip to main content
See every side of every news story
Published • loading... • Updated

What Cipher Pharmaceuticals (CPH) Said on Its Q3 Earnings Call

Summary by MarketBeat
Cipher Pharmaceuticals (TSE:CPH) reported nearly flat third-quarter revenue as growth in its Canadian acne treatment Epuris and higher licensing revenue largely offset lower U.S. sales of Natroba. Net income almost doubled, helped by the recognition of proceeds from an arbitration award. Revenue fo

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thecerbatgem.com broke the news on Friday, November 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal